共同药业：8月5日召开董事会会议

Group 1 - The company, Gongtong Pharmaceutical, announced the convening of its third board meeting on August 5, 2025, to discuss asset acquisition and related transactions [2] - For the year 2024, Gongtong Pharmaceutical's revenue composition is entirely from the manufacturing of steroid drug raw materials, accounting for 100.0% [2]